Soft Discoidal Polymeric Nanoconstructs Resist Macrophage Uptake and Enhance Vascular Targeting in Tumors.
暂无分享,去创建一个
Jaehong Key | Minjung Cho | Francesco Gentile | Paolo Decuzzi | Yeonju Lee | Jaykrishna Singh | P. Decuzzi | E. De Rosa | Minjung Cho | J. Key | F. Gentile | Jaykrishna Singh | Yeonju Lee | S. Aryal | Santosh Aryal | Anna Lisa Palange | Cinzia Stigliano | Daniele Di Mascolo | Enrica De Rosa | A. Palange | D. Di Mascolo | C. Stigliano
[1] M. Uesaka,et al. Accumulation of sub-100 nm polymeric micelles in poorly permeable tumours depends on size. , 2011, Nature nanotechnology.
[2] X. Zhao,et al. Lithographically defined uniform worm-shaped polymeric nanoparticles , 2010, Nanotechnology.
[3] Matthew D. McDermott,et al. The hydrogel template method for fabrication of homogeneous nano/microparticles. , 2010, Journal of controlled release : official journal of the Controlled Release Society.
[4] Paolo Decuzzi,et al. On the near-wall accumulation of injectable particles in the microcirculation: smaller is not better , 2013, Scientific Reports.
[5] Samir Mitragotri,et al. Particle shape: a new design parameter for micro- and nanoscale drug delivery carriers. , 2007, Journal of controlled release : official journal of the Controlled Release Society.
[6] Samir Mitragotri,et al. Control of endothelial targeting and intracellular delivery of therapeutic enzymes by modulating the size and shape of ICAM-1-targeted carriers. , 2008, Molecular therapy : the journal of the American Society of Gene Therapy.
[7] S. Gambhir,et al. Molecular imaging in living subjects: seeing fundamental biological processes in a new light. , 2003, Genes & development.
[8] Warren C W Chan,et al. Elucidating the mechanism of cellular uptake and removal of protein-coated gold nanoparticles of different sizes and shapes. , 2007, Nano letters.
[9] S. V. Sreenivasan,et al. Mammalian cells preferentially internalize hydrogel nanodiscs over nanorods and use shape-specific uptake mechanisms , 2013, Proceedings of the National Academy of Sciences.
[10] Ashutosh Chilkoti,et al. Nanomaterials for Drug Delivery , 2012, Science.
[11] Li Shi,et al. Nanoimprint lithography based fabrication of shape-specific, enzymatically-triggered smart nanoparticles. , 2008, Journal of controlled release : official journal of the Controlled Release Society.
[12] Warren C W Chan,et al. The effect of nanoparticle size, shape, and surface chemistry on biological systems. , 2012, Annual review of biomedical engineering.
[13] S. Wise. Nanocarriers as an emerging platform for cancer therapy , 2007 .
[14] Jinming Gao,et al. Polymeric Nanomedicine for Cancer MR Imaging and Drug Delivery , 2009 .
[15] M. Ferrari. Cancer nanotechnology: opportunities and challenges , 2005, Nature Reviews Cancer.
[16] J Szebeni,et al. Stealth liposomes and long circulating nanoparticles: critical issues in pharmacokinetics, opsonization and protein-binding properties. , 2003, Progress in lipid research.
[17] Mark E. Davis,et al. Nanoparticle therapeutics: an emerging treatment modality for cancer , 2008, Nature Reviews Drug Discovery.
[18] M A Fischl,et al. Pegylated-liposomal doxorubicin versus doxorubicin, bleomycin, and vincristine in the treatment of AIDS-related Kaposi's sarcoma: results of a randomized phase III clinical trial. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[19] Ji Guo,et al. Nanofabricated particles for engineered drug therapies: a preliminary biodistribution study of PRINT nanoparticles. , 2007, Journal of controlled release : official journal of the Controlled Release Society.
[20] Mauro Ferrari,et al. The association of silicon microparticles with endothelial cells in drug delivery to the vasculature. , 2009, Biomaterials.
[21] M. Steven Greene,et al. Quantifying uncertainties in the microvascular transport of nanoparticles , 2014, Biomechanics and modeling in mechanobiology.
[22] Michael Hawkins,et al. Phase III trial of nanoparticle albumin-bound paclitaxel compared with polyethylated castor oil-based paclitaxel in women with breast cancer. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[23] Ralph Weissleder,et al. Multifunctional magnetic nanoparticles for targeted imaging and therapy. , 2008, Advanced drug delivery reviews.
[24] Ying Liu,et al. Cellular uptake, intracellular trafficking, and cytotoxicity of nanomaterials. , 2011, Small.
[25] Vladimir P Torchilin,et al. Multifunctional nanocarriers. , 2006, Advanced drug delivery reviews.
[26] Anne L. van de Ven,et al. Synthetic nanoparticles functionalized with biomimetic leukocyte membranes possess cell-like functions. , 2013, Nature nanotechnology.
[27] J. V. Von Roenn,et al. Randomized phase III trial of liposomal daunorubicin versus doxorubicin, bleomycin, and vincristine in AIDS-related Kaposi's sarcoma. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[28] M. Ferrari,et al. Intracellular trafficking of silicon particles and logic-embedded vectors. , 2010, Nanoscale.
[29] L. Lartigue,et al. Biodegradation of iron oxide nanocubes: high-resolution in situ monitoring. , 2013, ACS nano.
[30] R. Jain,et al. Delivering nanomedicine to solid tumors , 2010, Nature Reviews Clinical Oncology.
[31] Igor Sokolov,et al. Method for quantitative measurements of the elastic modulus of biological cells in AFM indentation experiments. , 2013, Methods.
[32] E. Cosgriff-Hernandez,et al. Determination of the in vivo degradation mechanism of PEGDA hydrogels. , 2014, Journal of biomedical materials research. Part A.
[33] K. Beningo,et al. Fc-receptor-mediated phagocytosis is regulated by mechanical properties of the target. , 2002, Journal of cell science.
[34] Mauro Ferrari,et al. Intravascular Delivery of Particulate Systems: Does Geometry Really Matter? , 2008, Pharmaceutical Research.
[35] Samir Mitragotri,et al. Polymer particle shape independently influences binding and internalization by macrophages. , 2010, Journal of controlled release : official journal of the Controlled Release Society.
[36] Joseph M. DeSimone,et al. Using mechanobiological mimicry of red blood cells to extend circulation times of hydrogel microparticles , 2011, Proceedings of the National Academy of Sciences.
[37] Joseph M. DeSimone,et al. Strategies in the design of nanoparticles for therapeutic applications , 2010, Nature Reviews Drug Discovery.
[38] Mauro Ferrari,et al. Rapid tumoritropic accumulation of systemically injected plateloid particles and their biodistribution. , 2012, Journal of controlled release : official journal of the Controlled Release Society.
[39] M. Ferrari,et al. Discoidal Porous Silicon Particles: Fabrication and Biodistribution in Breast Cancer Bearing Mice , 2012, Advanced functional materials.
[40] Mauro Ferrari,et al. Mesoporous silicon particles as a multistage delivery system for imaging and therapeutic applications. , 2008, Nature nanotechnology.
[41] Mary E Napier,et al. More effective nanomedicines through particle design. , 2011, Small.
[42] R. Jain,et al. Strategies for advancing cancer nanomedicine. , 2013, Nature materials.
[43] M Ferrari,et al. Size and shape effects in the biodistribution of intravascularly injected particles. , 2010, Journal of controlled release : official journal of the Controlled Release Society.
[44] E Kent Yucel,et al. MR angiography of aortoiliac occlusive disease: a phase III study of the safety and effectiveness of the blood-pool contrast agent MS-325. , 2005, Radiology.
[45] Stephanie E. A. Gratton,et al. The effect of particle design on cellular internalization pathways , 2008, Proceedings of the National Academy of Sciences.
[46] M. Bawendi,et al. Renal clearance of quantum dots , 2007, Nature Biotechnology.
[47] Robert Langer,et al. Self-assembled lipid--polymer hybrid nanoparticles: a robust drug delivery platform. , 2008, ACS nano.
[48] Dong Chen,et al. The shape effect of mesoporous silica nanoparticles on biodistribution, clearance, and biocompatibility in vivo. , 2011, ACS nano.
[49] S. Mitragotri,et al. Elasticity of nanoparticles influences their blood circulation, phagocytosis, endocytosis, and targeting. , 2015, ACS nano.
[50] Samir Mitragotri,et al. Physical approaches to biomaterial design. , 2009, Nature materials.